Logo image of CBSM.PA

SCBSM (CBSM.PA) Stock Fundamental Analysis

EPA:CBSM - Euronext Paris - Matif - FR0006239109 - REIT - Currency: EUR

8.9  0 (0%)

Fundamental Rating

5

Taking everything into account, CBSM scores 5 out of 10 in our fundamental rating. CBSM was compared to 42 industry peers in the Diversified REITs industry. CBSM has only an average score on both its financial health and profitability. CBSM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CBSM was profitable.
CBSM had a positive operating cash flow in the past year.
In the past 5 years CBSM has always been profitable.
Each year in the past 5 years CBSM had a positive operating cash flow.
CBSM.PA Yearly Net Income VS EBIT VS OCF VS FCFCBSM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

1.2 Ratios

CBSM has a worse Return On Assets (0.07%) than 66.67% of its industry peers.
CBSM has a worse Return On Equity (0.13%) than 66.67% of its industry peers.
The Return On Invested Capital of CBSM (2.70%) is worse than 69.05% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CBSM is in line with the industry average of 3.60%.
The last Return On Invested Capital (2.70%) for CBSM is above the 3 year average (2.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.07%
ROE 0.13%
ROIC 2.7%
ROA(3y)2.98%
ROA(5y)3.77%
ROE(3y)6.05%
ROE(5y)7.76%
ROIC(3y)2.45%
ROIC(5y)2.41%
CBSM.PA Yearly ROA, ROE, ROICCBSM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

CBSM has a Profit Margin of 1.52%. This is in the lower half of the industry: CBSM underperforms 66.67% of its industry peers.
In the last couple of years the Profit Margin of CBSM has declined.
CBSM has a better Operating Margin (76.80%) than 66.67% of its industry peers.
In the last couple of years the Operating Margin of CBSM has grown nicely.
The Gross Margin of CBSM (75.65%) is comparable to the rest of the industry.
CBSM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 76.8%
PM (TTM) 1.52%
GM 75.65%
OM growth 3Y2.2%
OM growth 5Y4.35%
PM growth 3Y-74.65%
PM growth 5Y-58.24%
GM growth 3Y2.33%
GM growth 5Y3.97%
CBSM.PA Yearly Profit, Operating, Gross MarginsCBSM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBSM is destroying value.
The number of shares outstanding for CBSM has been reduced compared to 1 year ago.
Compared to 5 years ago, CBSM has more shares outstanding
Compared to 1 year ago, CBSM has an improved debt to assets ratio.
CBSM.PA Yearly Shares OutstandingCBSM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CBSM.PA Yearly Total Debt VS Total AssetsCBSM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

CBSM has an Altman-Z score of 1.24. This is a bad value and indicates that CBSM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CBSM (1.24) is better than 78.57% of its industry peers.
CBSM has a debt to FCF ratio of 12.16. This is a negative value and a sign of low solvency as CBSM would need 12.16 years to pay back of all of its debts.
With a Debt to FCF ratio value of 12.16, CBSM perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
CBSM has a Debt/Equity ratio of 0.76. This is a neutral value indicating CBSM is somewhat dependend on debt financing.
CBSM's Debt to Equity ratio of 0.76 is in line compared to the rest of the industry. CBSM outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 12.16
Altman-Z 1.24
ROIC/WACC0.56
WACC4.85%
CBSM.PA Yearly LT Debt VS Equity VS FCFCBSM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

CBSM has a Current Ratio of 3.07. This indicates that CBSM is financially healthy and has no problem in meeting its short term obligations.
CBSM's Current ratio of 3.07 is amongst the best of the industry. CBSM outperforms 97.62% of its industry peers.
A Quick Ratio of 3.07 indicates that CBSM has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.07, CBSM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 3.07
CBSM.PA Yearly Current Assets VS Current LiabilitesCBSM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

CBSM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.45%.
CBSM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -54.71% yearly.
CBSM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.16%.
CBSM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)-96.45%
EPS 3Y-71.89%
EPS 5Y-54.71%
EPS Q2Q%405.2%
Revenue 1Y (TTM)8.16%
Revenue growth 3Y7.97%
Revenue growth 5Y6.51%
Sales Q2Q%8.4%

3.2 Future

Based on estimates for the next years, CBSM will show a very strong growth in Earnings Per Share. The EPS will grow by 239.41% on average per year.
CBSM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.32% yearly.
EPS Next Y3300%
EPS Next 2Y511.56%
EPS Next 3Y239.41%
EPS Next 5YN/A
Revenue Next Year-9.89%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.32%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CBSM.PA Yearly Revenue VS EstimatesCBSM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
CBSM.PA Yearly EPS VS EstimatesCBSM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 296.67 indicates a quite expensive valuation of CBSM.
Based on the Price/Earnings ratio, CBSM is valued a bit more expensive than the industry average as 69.05% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.99. CBSM is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 10.91, which indicates a very decent valuation of CBSM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBSM indicates a somewhat cheap valuation: CBSM is cheaper than 61.90% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.36. CBSM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 296.67
Fwd PE 10.91
CBSM.PA Price Earnings VS Forward Price EarningsCBSM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

CBSM's Enterprise Value to EBITDA ratio is in line with the industry average.
90.48% of the companies in the same industry are more expensive than CBSM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.51
EV/EBITDA 17.39
CBSM.PA Per share dataCBSM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CBSM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBSM's earnings are expected to grow with 239.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y511.56%
EPS Next 3Y239.41%

More info and screens

0

5. Dividend

5.1 Amount

CBSM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCBSM

EPA:CBSM (8/5/2025, 7:00:00 PM)

8.9

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)03-27 2025-03-27
Earnings (Next)09-29 2025-09-29
Inst Owners0.08%
Inst Owner ChangeN/A
Ins Owners52.35%
Ins Owner ChangeN/A
Market Cap122.20M
Analysts82.86
Price Target11.12 (24.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 296.67
Fwd PE 10.91
P/S 5.65
P/FCF 7.51
P/OCF 7.51
P/B 0.48
P/tB 0.48
EV/EBITDA 17.39
EPS(TTM)0.03
EY0.34%
EPS(NY)0.82
Fwd EY9.17%
FCF(TTM)1.18
FCFY13.31%
OCF(TTM)1.18
OCFY13.31%
SpS1.57
BVpS18.45
TBVpS18.45
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.07%
ROE 0.13%
ROCE 3.68%
ROIC 2.7%
ROICexc 2.9%
ROICexgc 2.9%
OM 76.8%
PM (TTM) 1.52%
GM 75.65%
FCFM 75.24%
ROA(3y)2.98%
ROA(5y)3.77%
ROE(3y)6.05%
ROE(5y)7.76%
ROIC(3y)2.45%
ROIC(5y)2.41%
ROICexc(3y)2.67%
ROICexc(5y)2.6%
ROICexgc(3y)2.67%
ROICexgc(5y)2.6%
ROCE(3y)3.33%
ROCE(5y)3.29%
ROICexcg growth 3Y5.51%
ROICexcg growth 5Y3.74%
ROICexc growth 3Y5.51%
ROICexc growth 5Y3.74%
OM growth 3Y2.2%
OM growth 5Y4.35%
PM growth 3Y-74.65%
PM growth 5Y-58.24%
GM growth 3Y2.33%
GM growth 5Y3.97%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 12.16
Debt/EBITDA 11.65
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.94
Cash Conversion 97.94%
Profit Quality 4959.76%
Current Ratio 3.07
Quick Ratio 3.07
Altman-Z 1.24
F-Score7
WACC4.85%
ROIC/WACC0.56
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)1716.66%
Profit Quality(5y)1054.82%
High Growth Momentum
Growth
EPS 1Y (TTM)-96.45%
EPS 3Y-71.89%
EPS 5Y-54.71%
EPS Q2Q%405.2%
EPS Next Y3300%
EPS Next 2Y511.56%
EPS Next 3Y239.41%
EPS Next 5YN/A
Revenue 1Y (TTM)8.16%
Revenue growth 3Y7.97%
Revenue growth 5Y6.51%
Sales Q2Q%8.4%
Revenue Next Year-9.89%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.32%
Revenue Next 5YN/A
EBIT growth 1Y10.84%
EBIT growth 3Y10.34%
EBIT growth 5Y11.14%
EBIT Next Year2.59%
EBIT Next 3Y4.54%
EBIT Next 5YN/A
FCF growth 1Y10.82%
FCF growth 3Y5.08%
FCF growth 5Y22.16%
OCF growth 1Y10.82%
OCF growth 3Y5.08%
OCF growth 5Y22.16%